Market Overview:
The global oligonucleotide synthesis market reached a value of US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2027, exhibiting a CAGR of 12.71% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Oligonucleotide synthesis is a chemical process wherein short fragments of nucleic acids are linked to each other for forming desired sequenced products. It can be customized by researchers according to the application and their requirements. It is used as primers and probes in recombinant DNA technologies to develop monoclonal antibodies. It is also utilized in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening. Moreover, it is gaining traction in therapeutics practices for several drugs on account of the introduction of automated reactor platforms, which provide access to oligonucleotides at reasonable prices.
With the increasing cases of coronavirus disease (COVID-19) and the urgency for a potential treatment, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are currently under development. Apart from this, the growing incidences of cancer and other chronic illnesses have resulted in the rising demand for novel diagnostics, which is influencing the need for oligonucleotide synthesis to help develop effective therapies and diagnostic techniques. The increasing geriatric population and demand for personalized medicines are also bolstering the market growth. Additionally, with advances in purification and quality control technologies, the overall cost of oligonucleotide techniques can be decreased while substantially increasing quality and yield. This is promoting the application of oligonucleotide synthesis in a range of available modifications. Apart from this, several oligonucleotide-based therapies are in different stages of clinical trials. This is anticipated to propel the demand for oligonucleotide synthesis to treat viral infections, rare genetic disorders, and neuromuscular conditions.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oligonucleotide synthesis market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end use.
Breakup by Product:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
Breakup by Application:
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In-Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic Research Institutes
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Application, End Use, Region |
| Region Covered |
North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia, Brazil, Mexico |
| Companies Covered |
Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Oligonucleotide Synthesis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Synthesized Oligonucleotide Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Equipment
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Services
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 PCR Primers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 PCR Assays and Panels
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 DNA Microarrays
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Fluorescence In-Situ Hybridization (FISH)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Antisense Oligonucleotides
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End Use
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital and Diagnostic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Biolegio B.V.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-Synthesis Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Eurofins Genomics
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 GenScript
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Horizon Discovery Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Integrated DNA Technologies Inc (Danaher Corporation)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Kaneka Eurogentec S.A. (Kaneka Corporation)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LGC Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Oligonucleotide Synthesis Market: Major Drivers and Challenges
Figure 2: Global: Oligonucleotide Synthesis Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Oligonucleotide Synthesis Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Oligonucleotide Synthesis Market: Breakup by Product (in %), 2021
Figure 5: Global: Oligonucleotide Synthesis Market: Breakup by Application (in %), 2021
Figure 6: Global: Oligonucleotide Synthesis Market: Breakup by End Use (in %), 2021
Figure 7: Global: Oligonucleotide Synthesis Market: Breakup by Region (in %), 2021
Figure 8: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Oligonucleotide Synthesis (Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Oligonucleotide Synthesis (Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Oligonucleotide Synthesis (Equipment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Oligonucleotide Synthesis (Equipment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Oligonucleotide Synthesis (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Oligonucleotide Synthesis (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Oligonucleotide Synthesis (PCR Primers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Oligonucleotide Synthesis (PCR Primers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Oligonucleotide Synthesis (Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Oligonucleotide Synthesis (Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Oligonucleotide Synthesis (DNA Microarrays) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Oligonucleotide Synthesis (DNA Microarrays) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Oligonucleotide Synthesis (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Oligonucleotide Synthesis (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Oligonucleotide Synthesis Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Oligonucleotide Synthesis Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Oligonucleotide Synthesis Industry: SWOT Analysis
Figure 86: Global: Oligonucleotide Synthesis Industry: Value Chain Analysis
Figure 87: Global: Oligonucleotide Synthesis Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Oligonucleotide Synthesis Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Oligonucleotide Synthesis Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 5: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Oligonucleotide Synthesis Market: Competitive Structure
Table 7: Global: Oligonucleotide Synthesis Market: Key Players